The first known entry of private equity (PE) in the clinical dermatology space was more than a decade ago. By 2020 there were more than 30 PE-backed dermatology groups. Gastroenterology practices are now experiencing a similar trend of explosive PE growth.
Writing in Clinical Gastroenterology and Hepatology (CGH), Drs. Mark Gilreath, Neal Patel, John Suh and Joel V. Brill discuss the acceleration of GI practice consolidation over the past two years, continuing market forces, and the effects of COVID-19 on private practice. Read their commentary in the June issue of CGH: Gastroenterology Physician Practice Management and Private Equity: Thriving in Uncertain Times.
